Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 3/20 | 0.32 |
| ▸ | CA1 | P00915 | 3/20 | 0.32 |
| ▸ | CA2 | P00918 | 3/20 | 0.32 |
| ▸ | CA9 | Q16790 | 3/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2478796 | 0.72 | CA12 (0.35) | CA12CA1CA2CA9CYP1A2 | |
| SCHEMBL21141394 | 0.71 | PIK3CD (0.33) | CA12CA1CA2CA9CYP1A2 | |
| SCHEMBL11213322 | 0.69 | ALDH1A1 (0.35) | — | |
| SCHEMBL7056685 | 0.69 | TSHR (0.44) | CA12CA1CA2CA9 | |
| SCHEMBL21141114 | 0.69 | — | — | |
| SCHEMBL20119102 | 0.67 | PIK3CD (0.31) | — | |
| SCHEMBL3903707 | 0.67 | CA12 (0.38) | CA12CA1CA2CA9CYP1A2 | |
| SCHEMBL3461429 | 0.67 | MAPK1 (0.35) | CA12CA1CA2CA9CYP1A2 | |
| SCHEMBL19333307 | 0.67 | CYP1A2 (0.38) | CA12CA1CA2CA9CYP1A2 | |
| SCHEMBL7931272 | 0.67 | CA12 (0.36) | CA12CA1CA2CA9CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3010926-B1 | ALKYLATION WITH AN ALKYL FLUOROALKYL SULFONATE | NOVARTIS AG (CH) | 2019-11-20 | — | — | EP | claimed |
| US-20160130280-A1 | ALKYLATION WITH AN ALKYL FLUOROALKYL SULFONATE | NOVARTIS AG (CH) | 2016-05-12 | — | — | US | claimed |
| EP-3010926-A1 | ALKYLATION WITH AN ALKYL FLUOROALKYL SULFONATE | Novartis AG (CH) | 2016-04-27 | — | — | EP | claimed |
| WO-2014203185-A1 | ALKYLATION WITH AN ALKYL FLUOROALKYL SULFONATE | NOVARTIS AG (CH) | 2014-12-24 | — | — | WO | claimed |
| EP-0371528-B1 | Triboelectrically processable powder coating | DSM NV (NL) | 1994-03-30 | — | — | EP | claimed |
| US-5124387-A | Polyester binder, tertiary amine additive | DSM N.V. (NL) | 1992-06-23 | — | — | US | claimed |
| EP-0371528-A1 | Triboelectrically processable powder coating | DSM N.V. (NL) | 1990-06-06 | — | — | EP | claimed |
| CN-109651396-B | Alkylation of alkyl fluoroalkylsulfonates | 诺华股份有限公司 | 2021-09-14 | — | — | CN | disclosed |
| CN-107735398-B | Process for the synthesis of rapamycin derivatives | 赛比亚斯药业股份公司 | 2020-07-31 | — | — | CN | disclosed |
| EP-3010926-B1 | ALKYLATION WITH AN ALKYL FLUOROALKYL SULFONATE | NOVARTIS AG (CH) | 2019-11-20 | — | — | EP | disclosed |
| EP-3010926-B1 | ALKYLATION WITH AN ALKYL FLUOROALKYL SULFONATE | NOVARTIS AG (CH) | 2019-11-20 | — | — | EP | disclosed |
| US-10308665-B2 | Method for the synthesis of rapamycin derivatives | SYNBIAS PHARMA AG (CH) | 2019-06-04 | — | — | US | disclosed |
| EP-3313853-B1 | METHOD FOR THE SYNTHESIS OF RAPAMYCIN DERIVATIVES | SYNBIAS PHARMA AG (CH) | 2019-05-08 | — | — | EP | disclosed |
| EP-0519999-B1 | PREPARATION OF INDIUM ALKOXIDES SOLUBLE IN ORGANIC SOLVENTS | EASTMAN KODAK CO (US) | 1995-06-14 | — | — | EP | disclosed |
| EP-0371528-B1 | Triboelectrically processable powder coating | DSM NV (NL) | 1994-03-30 | — | — | EP | disclosed |
| US-5237081-A | Reacting indium halide with alcohol in presence of strong non-nucleophilic base, in anhydrous polar solvent, under inert gas | EASTMAN KODAK COMPANY (US) | 1993-08-17 | — | — | US | disclosed |
| EP-0519999-A1 | PREPARATION OF INDIUM ALKOXIDES SOLUBLE IN ORGANIC SOLVENTS. | EASTMAN KODAK CO (US) | 1992-12-30 | — | — | EP | disclosed |
| US-5124387-A | Polyester binder, tertiary amine additive | DSM N.V. (NL) | 1992-06-23 | — | — | US | disclosed |
| WO-1991013848-A1 | PREPARATION OF INDIUM ALKOXIDES SOLUBLE IN ORGANIC SOLVENTS | KODAK-PATHE (FR) | 1991-09-19 | — | — | WO | disclosed |
| EP-0371528-A1 | Triboelectrically processable powder coating | DSM N.V. (NL) | 1990-06-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10308665-B2 | Method for the synthesis of rapamycin derivatives | RICTOR, MTOR, MLST8 | CA12 3899/4885CA1 1677/4885CA2 1467/4885 |
| US-20160130280-A1 | ALKYLATION WITH AN ALKYL FLUOROALKYL SULFONATE | RICTOR, SULT2A1, POR | CA12 3401/4885CA1 3430/4885CA2 1996/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.